Floatz logo

Naproxen

Pain;Back Low;Chronic

Northwestern UniversitySmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Pain;Back Low;Chronic cohort.

Asset / SponsorPhaseRating
LEVODOPA
Northwestern University
Phase 2CCC
carbidopa
Northwestern University
Phase 2CCC

Same molecule, other indications

Naproxen is also rated in:

migraine disorderDormant
A
Indicative ·
80 / 100
View asset →
migraine disorderDormant
BBB
Indicative ·
72 / 100
View asset →
headache disorderDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →